Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Plans U.K.-Wide Bexsero Vaccination Campaign, Sells Other Meningitis Vaccines To Pfizer

This article was originally published in The Pink Sheet Daily

Executive Summary

Two vaccination campaigns will start in the U.K. this summer, one featuring GSK’s meningitis B vaccine Bexsero, recently acquired from Novartis, and the other vaccines against a growing threat from W strain meningococcus, as GSK plans to divest its own meningitis vaccines to Pfizer.

Advertisement

Related Content

Swapping Assets Now Down To Execution For GSK And Novartis
Pressure For Bexsero: Fate Of Novartis Vaccines Unit Hangs On Success

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS078616

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel